The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Open accessAbstract
The tumor suppressor p53 is activated upon genotoxic and oxidative stress and in turn inhibits cell proliferation and growth through induction of specific target genes. Cell growth is positively regulated by mTOR, whose activity is inhibited by the TSC1:TSC2 complex. Although genotoxic stress has been suggested to inhibit mTOR via p53-mediated activation of mTOR inhibitors, the precise mechanism of this link was unknown. We now demonstrate that the products of two p53 target genes, Sestrin1 and Sestrin2, activate the AMP-responsive protein kinase (AMPK) and target it to phosphorylate TSC2 and stimulate its GAP activity, thereby inhibiting mTOR. Correspondingly, Sestrin2-deficient mice fail to inhibit mTOR signaling upon genotoxic challenge. Sestrin1 and Sestrin2 therefore provide an important link between genotoxic stress, p53 and the mTOR signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, p53 uses two direct target genes, SESN1 and SESN2, to block mTOR and to repress mRNA translation.211, 215”
From Census and evaluation of p53 target genes (2017) · cites this paper as [211]
In the citing paper
“P53 can further block mTOR activity through its direct target genes SESN1 and SESN2.211”
From Census and evaluation of p53 target genes (2017) · cites this paper as [211]
In the citing paper
“Sestrins are able to bind AMPK activating it and, by this mechanism, repress mTORC1 activity (Budanov and Karin, 2008).”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Budanov and Karin, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,351
Cited by
Sorted by citations
Items 801–900 of 1,000
Injury primes mutation-bearing astrocytes for dedifferentiation in later life
Ragdale, H. S., Clements, M., Tang, W., Deltcheva, E. M., Andreassi, C., Lai, A. G., Chang, W. H., Pandrea, M., Andrew, I., Gamé, L., et al. (2023) · Current Biology · doi:10.1016/j.cub.2023.02.013 · Cited by 20
“p53 is known to suppress mTOR signaling through direct transcriptional upregulation of Phlda3,(49) Sestrin1, and Sestrin2.(50) To determine whether any of these genes are direct p53 targets in astrocytes, we performed ChIP sequencing analysis in wild-type cells and correlated it to our scRNA-seq data.”
The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin
Chaulin, A. M. (2023) · Life · doi:10.3390/life13112148 · Cited by 24
“Mice with knockout sestrin 1 and sestrin 2 genes were more vulnerable to doxorubicin-induced cardiac diseases, demonstrated more significant cardiac dysfunction, and their histological examination revealed that a greater number of cardiomyocytes were in apoptosis [92–94].”
BackgroundAltered radiation responses of breast cancer cells resistant to hormonal therapy
Luzhna, L., Lykkesfeldt, A. E., & Kovalchuk, O. (2014) · Oncotarget · doi:10.18632/oncotarget.3188 · Cited by 22
“P53-mediated activation of sestrin upon genotoxic stress inhibits mTOR through the AMPresponsive protein kinase (AMPK) [44].”
BackgroundLeft‐right asymmetry in the light of TOR: An update on what we know so far
Tena, T. C., Burkhalter, M. D., & Philipp, M. (2015) · Biology of the Cell · doi:10.1111/boc.201400094 · Cited by 20
“Fibroblasts of this patient displayed a marked reduction of sestrin1, which was identified as an inhibitor of TORC1 upstream of TSC proteins (Budanov and Karin, 2008).”
BackgroundTargeting Metabolism and Autophagy in the Context of Haematologic Malignancies
Banerji, V., & Gibson, S. B. (2012) · International Journal of Cell Biology · doi:10.1155/2012/595976 · Cited by 20
“p53 activation and mTORC1 activity [73, 78].”
Guardian of corpulence: a hypothesis on p53 signaling in the fat cell
Bazuine, M., Stenkula, K. G., Cam, M., Arroyo, M., & Cushman, S. W. (2009) · Clinical Lipidology · doi:10.2217/clp.09.2 · Cited by 21
Tsilioni, I., Filippidis, A., Kerenidi, T., Budanov, A. V., Zarogiannis, S. G., & Gourgoulianis, K. I. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.02.002 · Cited by 21
“Sesn2 is pivotal in p53-dependent antioxidant defenses because it reduces the oxidized form of peroxiredoxins and by inhibiting the TORC-1 anabolic pathway [8].”
BackgroundSelf-citationMolecular Pathogenesis of Liver Injury in Hereditary Tyrosinemia 1
Tanguay, R. M., Angileri, F., & Vogel, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55780-9_4 · Cited by 21
Genotoxic stress-mediated cell cycle activities for the decision of cellular fate
Erol, A. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17460 · Cited by 21
Storozhuk, Y., Sanli, T., Hopmans, S., Schultz, C., Farrell, T., Cutz, J., Steinberg, G. R., Wright, J. R., Singh, G., & Tsakiridis, T. K. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-71 · Cited by 21
“The specific mechanism and transcription factors involved in these events remain to be elucidated but studies suggest involvement of the p53-dependent stress-responsive genes Sestrin 1 and 2 [18].”
BackgroundTargeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases
Ambrosio, S., & Majello, B. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518765743 · Cited by 21
p53-regulated SESN1 and SESN2 regulate cell proliferation and cell death through control of STAT3
Haidurov, A., Zheltukhin, A. O., Snezhkina, A. V., Krasnov, G. S., Kudryavtseva, A. V., & Budanov, A. V. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02104-3 · Cited by 20
“To investigate Sestrins’ inhibitory effect on mTORC1 [25], we analysed phosphorylation of mTORC1 targets (p70S6K, S6, 4EBP1, and ULK1) in control and two distinct SESN1&2 knockout A549 cell lines [9].”
InfluentialSelf-citationp53 Protects Cells from Death at the Heatstroke Threshold Temperature
Gong, L., Zhang, Q., Pan, X., Chen, S., Yang, L., Liu, B., Yang, W., Yu, L., Xiao, Z. J., Feng, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.032 · Cited by 20
Chen, Z., Zhang, W., Wang, F., Mu, R., & Wen, D. (2021) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2021.109083 · Cited by 19
SESTRINs regulate mTORC1 via RRAGs: The riddle of GATOR
Budanov, A. V. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2014.997113 · Cited by 20
“TSC in turn is controlled by several stress insults via activation of 5 -AMP-activated protein kinase (AMPK), and we have shown previously that SESTRINs inhibit mTORC1 via the AMPK-TSC axis.(3) Amino acids and glucose control mTORC1 via RRAGs, which stimulate translocation of mTORC1 to the lysosomes where it can be ac…”
BackgroundSelf-citationRiccardin D induces cell death by activation of apoptosis and autophagy in osteosarcoma cells
Wang, Y., Ji, Y., Hu, Z., Jiang, H., Zhu, F., Yuan, H., & Lou, H. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.06.001 · Cited by 20
SESN2 correlates with advantageous prognosis in hepatocellular carcinoma
Chen, S., Yan, W., Lang, W., Yu, J., Xu, L., Xu, X., Liu, Y., & Bao, H. (2017) · Diagnostic Pathology · doi:10.1186/s13000-016-0591-2 · Cited by 20
“In addition, SESN2 expression inhibits cancer growth while increasing the sensitivity of cancer cells to ionizing radiation [15, 21].”
BackgroundResultInfluentialSestrin-like protein from Dictyostelium discoideum is involved in autophagy under starvation stress
Rafia, S., & Saran, S. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.12.006 · Cited by 20
Metallothionein Protects the Heart Against Myocardial Infarction via the mTORC2/FoxO3a/Bim Pathway
Xue, M., Joo, Y. A., Li, S., Niu, C. S., Chen, G., Yi, X., Liang, Y., Chen, Z., Shen, Y., Ye, W., et al. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7597 · Cited by 20
“Overexpression of MT can result in Zn sequestration (18), thus inhibiting the activation of p53, another zinc-binding protein and its key biochemical activity depends on the incorporation of zinc (15), and subsequently leading to the activation of mTORC2 (6).”
Chen, T., Li, T., & Wang, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10319 · Cited by 20
Sestrin proteins in cardiovascular disease
Sun, Y., Wu, Y., Tang, S., Liu, H., & Jiang, Y. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.013 · Cited by 20
Sestrin 2 controls the cardiovascular aging process via an integrated network of signaling pathways
Liu, Y., Du, X., Huang, Z., Zheng, Y., & Quan, N. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101096 · Cited by 20
Ranganayaki, S., Jamshidi, N., Aiyaz, M., Santhoshkumar, R., Gayathri, N., Harsha, P. K., Padmanabhan, B., & Bharath, M. M. S. (2021) · Scientific Reports · doi:10.1038/s41598-020-79339-2 · Cited by 20
A paradoxical role for sestrin 2 protein in tumor suppression and tumorigenesis
Qu, J., Luo, M., Zhang, J., Han, F., Hou, N., Pan, R., & Sun, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02317-9 · Cited by 21
“Sestrin 2, a homolog of the p53-activated gene 26, is encoded by the hypoxiainducible gene 95 [17].”
BackgroundTime Course Analysis of Skeletal Muscle Pathology of GDE5 Transgenic Mouse
Hashimoto, T., Yang, B., Okazaki, Y., Yoshizawa, I., Kajihara, K., Katô, N., Wada, M., & Yanaka, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163299 · Cited by 19
Lee, S., Pham, D., & Park, P. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01364-0 · Cited by 19
KDM1A/LSD1 as a promising target in various diseases treatment by regulating autophagy network
Ma, T., Li, A., Guo, Y., Li, S., Li, M., Feng, S., & Liu, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112762 · Cited by 19
Aerobic exercise ameliorates insulin resistance in C57BL/6 J mice via activating Sestrin3
Han, X., Yang, Y., Liu, S., Niu, Y., Shao, H., & Fu, L. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166568 · Cited by 19
Sestrin2 as a Protective Shield against Cardiovascular Disease
Zahid, M., Abdelsalam, S. S., Raïq, H., Parray, A., Korashy, H. M., Zeidan, A., Elrayess, M. A., & Agouni, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054880 · Cited by 20
“SESN2 affects the mTORC1 pathway in two different ways [8,20,30,31].”
BackgroundShared Gene Targets of the ATF4 and p53 Transcriptional Networks
Baniulyte, G., Durham, S. A., Merchant, L. E., & Sammons, M. A. (2023) · Molecular and Cellular Biology · doi:10.1080/10985549.2023.2229225 · Cited by 19
“Nutlin-3A treatment fails to induce expression of ATF3, GADD45A, SESN2, and GDF15 likely due to the loss-of-function TP53 S215G allele (Moder et al., 2017) in these cell lines.”
InfluentialThe p63 target HBP1 is required for skin differentiation and stratification
Borrelli, S., Candi, E., Hu, B., Dolfini, D., Ravo, M., Grober, O. M. V., Weisz, A., Dotto, G. P., Melino, G., Viganò, M., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.59 · Cited by 19
Klaus, A., Polge, C., Zorman, S., Auchli, Y., Brunisholz, R., & Schlattner, U. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.03.040 · Cited by 19
“AMPK signaling is known to respond to DNA damage and genotoxic stress transmitted via p53 and the p53 targets Sestrin1 and Sestrin2 [48] or the cellular damage sensor ataxia-telangiectasia mutated protein (ATM) [49].”
Drug Resistance and Molecular Cancer Therapy: Apoptosis Versus Autophagy
Trowman, R., Bryan, W., Nicholas, F., & Xu, L. (2013) · InTech eBooks · doi:10.5772/55415 · Cited by 20
Liu, L., QIU, S., LIU, Y., LIU, Z., Zheng, Y. G., Su, X., CHEN, B., & Hanbing, C. H. E. N. (2016) · Neoplasma · doi:10.4149/203_150422n214 · Cited by 19
Panebianco, C., Villani, A., & Pazienza, V. (2019) · Nutrients · doi:10.3390/nu11040709 · Cited by 19
“On the other hand, PIK3R1, PDK4, ARID5B, CPEB4, RGS2, SGK1, LPIN1, HDAC4, SLC19A2, CRY2, SOX4, DDIT4, FOXO3, PER1, SESN1, TP53INP1, MT1X, MT2P1, ZBTB16, and MT2A were significantly up-regulated in the mice fed with the RS diet, with respect to the control mice.”
BackgroundCompound C Increases Sestrin2 Expression via Mitochondria-Dependent ROS Production
Seo, K., Seo, S., Ki, S. H., & Shin, S. M. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00938 · Cited by 19
Carr, M. J., González, G., Martinelli, A., Wastika, C. E., Ito, K., Orba, Y., Sasaki, M., Hall, W. W., & Sawa, H. (2019) · Virus Genes · doi:10.1007/s11262-019-01683-x · Cited by 19
Sestrins are Gatekeepers in the Way from Stress to Aging and Disease
Dalina, A. A., Kovaleva, I. E., & Budanov, A. V. (2018) · Molecular Biology · doi:10.1134/s0026893318060043 · Cited by 20
Self-citationOh, H. J., Lee, S., & Park, P. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154959 · Cited by 18
Gao, F., Zhao, Y., Zhang, B., Xiao, C., Sun, Z., Gao, Y., & Dou, X. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-023-10176-z · Cited by 17
“Moreover, SESN1 is demonstrated to activate the AMPK/mTOR signaling (Lee et al. 2016; Budanov and Karin 2008).”
O’Neill, E. J., Sze, S. K., MacPherson, R. E. K., & Tsiani, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041950 · Cited by 21
“Sestrin-2 is a stress-induced protein that leads to the activation of AMPK signaling during conditions of nutrient deficiency, DNA damage, oxidative stress, or hypoxia [24,25].”
BackgroundFOXOs Maintaining the Equilibrium for Better or for Worse
van Doeselaar, S., & Burgering, B. M. T. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.003 · Cited by 17
Resveratrol-induced p53 activation is associated with autophagy in mouse embryonic stem cells
Suvorova, I. I., Knyazeva, A. R., & Pospelov, V. A. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.010 · Cited by 18
Song, S., Wu, S., Wang, Y., Wang, Z. P., Ye, C.-X., Song, R., Song, D., & Ruan, Y. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.10.021 · Cited by 18
“T mammalian target of rapamycin (mTOR) pathway, including adenosine monophosphate (AMP)-activated protein kinase (AMPK), tuberous sclerosis complex 2 (TSC2), and phosphatase-tensin homolog (PTEN) (Budanov and Karin, 2008; Feng et al., 2007), which suggests that p53 is an activator of autophagy (Feng and Levine, 2010).”
Luo, C., Zheng, N., Zhao, S., & Wang, J. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b00716 · Cited by 17
Sestrin2 is involved in asthma: a case–control study
Kang, Y., Chen, C., Hu, X., Du, X., Zhai, H., Fang, Y., Ye, X., Yang, W., & Sun, S. (2019) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-019-0360-3 · Cited by 18
Hayashi, Y., Asuzu, D. T., Bardsley, M. R., Gajdos, G. B., Kvasha, S. M., Linden, D. R., Nagy, R. A., Saravanaperumal, S. A., Syed, S. A., Toyomasu, Y., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.07.011 · Cited by 18
Sestrin2 and mitochondrial quality control: Potential impact in myogenic differentiation
Piochi, L. F., Machado, I. F., Palmeira, C. M., & Rolo, A. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101309 · Cited by 21
p53 Inhibition Protects against Neuronal Ischemia/Reperfusion Injury by the p53/PRAS40/mTOR Pathway
Zhao, J., Dong, Y., Chen, X., Xiao, X., Tan, B., Chen, G., Hu, J., Qi, D., Li, X., & Xie, R. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4729465 · Cited by 18
“However, the speci fi c regulatory mechanisms linking the p53 and mTOR pathways need to be further explored [8].”
Conserved versatile master regulators in signalling pathways in response to stress in plants
Balderas‐Hernández, V. E., Alvarado-Rodríguez, M., & Fraire-Velázquez, S. (2013) · AoB Plants · doi:10.1093/aobpla/plt033 · Cited by 19
Molecular mechanisms and functions of autophagy and the ubiq-uitin-proteasome pathway
Chen, K., Cheng, H., & Zhou, R. (2012) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2012.00005 · Cited by 19
“损伤时, p53的激活可以促进AMPK的激活进而抑制 mTORC1的活性来诱导自噬([24])。此外, p53可以通过 转录激活自噬调节蛋白DRAM从而诱导细胞的自噬 ([25])。p53 的下游基因sestrin1 和sestrin2 也能够激活 AMPK的活性进而抑制mTORC1 的活性来诱导自噬 ([26])。但是最近的研究表明, 细胞质的p53抑制了细胞 的自噬([27])。 在哺乳动物细胞中 , 胰岛素(Insulin)可以通过 两个途径来抑制自噬:(1)在氨基酸的协同作用下激 活 mTOR使 Atg1/ULK1 磷酸化从而抑制自噬 ; (2)Insulin激活 PKB/Akt的活性从而使转录因子 FoxO3 磷酸化并抑…”
InfluentialBaroudi, M. E., Machiels, J., & Schmitz, S. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1373212 · Cited by 18
“In addition, SESN1 is an important regulator of homeostasis through the suppression of the mechanistic target of rapamycin complex 1 (mTORC1) kinase.(41-43) In a recent paper, Cordani et al demonstrated that the depletion of mutant TP53 determined an increase of SESN1 in a breast cancer cell line.”
BackgroundYang, Y., Peng, Y., Li, Y., Shi, T., Xu, N., Luan, Y., & Yin, C. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111518 · Cited by 17
Shimazu, K., Tada, Y., Morinaga, T., Shingyoji, M., Sekine, I., Shimada, H., Hiroshima, K., Namiki, T., Tatsumi, K., & Tagawa, M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3300-y · Cited by 17
Recent advances in amino acid sensing and new challenges for protein nutrition in aquaculture
Liu, C., Wang, X., Zhou, H., Mai, K., & He, G. (2019) · Marine Life Science & Technology · doi:10.1007/s42995-019-00022-1 · Cited by 18
P53-regulated autophagy and its impact on drug resistance and cell fate
Shim, D. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2020.85 · Cited by 20
“Feng Z, Hu W, de Stanchina E, et al.The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.”
BackgroundInfluentialAdhikari, S., Guha, D., Mohan, C., Mukherjee, S., Tyler, J. K., & Das, C. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_1 · Cited by 19
A review of the signaling pathways of aerobic and anaerobic exercise on atherosclerosis
Liu, S., Liu, Y., Liu, Z., Hu, Y., & Jiang, M. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.30989 · Cited by 18
“The inhibition of NLRP3 inflammasome by SESN1 is realized by SESN1/AMPK/mTORC1 signaling pathway (Budanov & Karin, 2008; Cordero et al., 2018).”
Backgroundp53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect
Abukwaik, R., Vera-Sigüenza, E., Tennant, D. A., & Spill, F. (2024) · Bulletin of Mathematical Biology · doi:10.1007/s11538-024-01346-5 · Cited by 19
“For instance, p53 induces the expression of proteins that activate AMPK, which in turn inhibits mTOR activity and its downstream target HIF1 (Budanov and Karin, 2008; Sanli et al., 2012; Feng and Levine, 2010).”
BackgroundHarnessing p53 for targeted cancer therapy: new advances and future directions
Andrysík, Z., & Espinosa, J. M. (2025) · Transcription · doi:10.1080/21541264.2025.2452711 · Cited by 19
Lee, S., Byun, J., Park, M., Kim, S. W., Lee, S., Kim, J., Lee, I., Choi, Y., & Park, K. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8638 · Cited by 17
“Sestrin2 suppresses mTORC1 signaling via activation of AMPK-activated protein kinase (AMPK) or inhibition of Rag GTPases (7,8).”
BackgroundResultSestrin2 inhibits YAP activation and negatively regulates corneal epithelial cell proliferation
Lee, J., Park, H., Cho, K. J., & Lyu, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0446-5 · Cited by 17
Khalil, H., ElHady, A. A., Elawdan, K. A., Mohamed, D. D., Mohamed, D. D., Maksoud, A. I. A. E., El-Chennawi, F. A., El-Fikiy, B., & El-Sayed, I. H. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1828453 · Cited by 18
“p53 wild type (wt) cells, while their genetic depletion enhanced mTORC1 activity in p53 wt cells (Budanov and Karin 2008; Chantranupong et al. 2014; Hay 2008; Peng et al. 2014).”
BackgroundMutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells
Ghaleb, A. M., Padellan, M., & Marchenko, N. D. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01370-y · Cited by 17
Amino acid sensory complex proteins in mTORC1 and macroautophagy regulation
Seibert, M., Kurrle, N., Schnütgen, F., & Serve, H. L. (2021) · Matrix Biology · doi:10.1016/j.matbio.2021.01.001 · Cited by 18
A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia
da Silva-Diz, V., Cao, B., Lancho, O., Chiles, E. N., Alasadi, A., Aleksandrova, M., Luo, S., Singh, A., Tao, H., Augeri, D. J., et al. (2021) · Blood · doi:10.1182/blood.2020008955 · Cited by 16
Enasescu, D. S. A., Moisescu, M. G., Imre, M. M., Greabu, M., Totan, A., Stănescu-Spînu, I.-I., Burcea, M., Albu, C.-C., & Miricescu, D. (2021) · Materials · doi:10.3390/ma14112968 · Cited by 17
“Its activation will depend on Sestrin 1 and 2, also controlled by p53 [36,43,44].”
BackgroundHPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PGC-1α/ERRα axis
Sannigrahi, M. K., Rajagopalan, P., Lai, L., Liu, X., Sahu, V., Nakagawa, H., Jalaly, J. B., Brody, R. M., Morgan, I. M., Windle, B. E., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159600 · Cited by 17
“Increased p53 also drives expression of sestrins (45), which mediate PGC-1 α activation by stimulating its phosphorylation by AMPK (46).”
Drugging in the absence of p53
Aning, O. A., & Cheok, C. F. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz012 · Cited by 16
Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts
Robles, A. J., Kurmasheva, R. T., Bandyopadhyay, A. M., Phelps, D. A., Erickson, S. W., Lai, Z., Kurmashev, D., Chen, Y., Smith, M. A., & Houghton, P. J. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1822 · Cited by 17
“Sestrins 1 and 2 (SESN1/2), induced downstream of DNA-damage-induced TP53, suggest that irinotecan may suppress TORC1 activity (44), that could affect DNA damage repair (45).”
BackgroundGnanapradeepan, K., Roy, S. B., Barnoud, T., Leu, J. I.-J., Good, M., Lee, J. V., Quinn, W. J., Kung, C.-P., Ahima, R. S., Baur, J. A., et al. (2020) · eLife · doi:10.7554/elife.55994 · Cited by 16
“p53 negatively regulates the mTOR pathway in part through transactivation of the target genes PTEN, TSC2, PRKAB1 and SESN1/SESN2 (Budanov and Karin, 2008; Feng et al., 2005).”
BackgroundInfluentialXiao, Y., Zhu, H., Lei, J., Xie, J., Wu, K., Gu, W., Ma, J., wei, D., Shu, Z., & Zhao, L. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0033 · Cited by 16
Gao, C., Wang, L., Fu, K., Cheng, S., Wang, S., Feng, Z., Yu, S., & Yang, Z. (2024) · Inflammation · doi:10.1007/s10753-024-02068-5 · Cited by 16
p53 and metabolism: Old player in a new game
Sen, N., Satija, Y. K., & Das, S. (2012) · Transcription · doi:10.4161/trns.20094 · Cited by 16
Sestrin family may play important roles in the regulation of cardiac pathophysiology
Liao, H.-H., Ruan, J., Liu, H.-J., Liu, Y., Feng, H., & Tang, Q. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.164 · Cited by 16
DNA damage regulates direct association of TOR kinase with the RNA polymerase II–transcribedHMO1gene
Panday, A., Gupta, A., Srinivasa, K., Xiao, L., Smith, M. D., & Grove, A. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-01-0024 · Cited by 16
“The cell-cycle arrest that accompanies unrepaired DNA damage must be coordinated with metabolic arrest, and this process requires mTORC1 (Shen et al., 2007; Budanov and Karin, 2008; Dulic, 2013).”
BackgroundGuo, L. J., Yao, J. H., Zheng, C., Tian, H. B., Liu, Y., Liu, S. M., Cai, C., Xu, X. R., & Cao, Y. (2019) · animal · doi:10.1017/s1751731118003683 · Cited by 17
Qin, Y., Sekine, I., Hanazono, M., Morinaga, T., Fan, M., Takiguchi, Y., Tada, Y., Shingyoji, M., Yamaguchi, N., & Tagawa, M. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12496 · Cited by 16
“In addition, the mTORC1 itself was regulated by not only AMPK but by other pathways (Budanov and Karin, 2008), which could result in cell type- and contextdependent mTORC1 responses.”
BackgroundChen, Y., Wang, C., Wei, M., Tzeng, Y.-S., Lan, K.-H., Cheng, A., & Kuo, S. (2019) · Cancers · doi:10.3390/cancers11081204 · Cited by 16
Experimental Approaches in Delineating mTOR Signaling
Qian, J., Su, S., & Liu, P. (2020) · Genes · doi:10.3390/genes11070738 · Cited by 17
“It was previously reported that as a stress-responsive gene, Sestrin 2 inhibited mTORC1 signaling through the AMPK/TSC signaling axis [55,56].”
BackgroundCorrelation between sestrin2 expression and airway remodeling in COPD
Zhang, D., Wei, Y., Ji, S., & Fei, G. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01329-x · Cited by 16
Gombos, Z., Koltai, E., Torma, F., Bakonyi, P., Kolonics, A., Aczél, D., Ditrói, T., Nagy, P., Kawamura, T., & Radak, Z. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147588 · Cited by 18
“Moreover, it has also been reported that in cell culture, knockdown of sestrin2 reduced AMPK and SOD2 levels [23], and we have observed simultaneous effect during overload induced hypertrophy.”
BackgroundInfluentialDNA methylation maintenance at the p53 locus initiates biliary-mediated liver regeneration
He, J., Zhou, Y., Qian, C., Wang, D., Yang, Z., Huang, Z., Sun, J., Ni, R., Yang, Q., Chen, J., et al. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00217-8 · Cited by 16
TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
Wang, H., Wang, X., Xu, L., & Zhang, J. (2022) · BMC Genomic Data · doi:10.1186/s12863-022-01059-5 · Cited by 16
Mlitz, V., Gendronneau, G., Berlin, I., Buchberger, M., Eckhart, L., & Tschachler, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166832 · Cited by 17
Liu, X., Wang, M., Sun, G.-Q., Wang, B., Jiang, K., Shao, J., Qi, C., Zhao, W., Han, S.-Y., Liu, M., et al. (2018) · Aquaculture Nutrition · doi:10.1111/anu.12688 · Cited by 16
Elevation of Sestrin-2 expression attenuates Sevoflurane induced neurotoxicity
Yi, W., Zhang, Y., Guo, Y., Li, D., & Li, X. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9673-1 · Cited by 17
“tioxidant defense of the cell (Budanov and Karin 2008).”
BackgroundInfluentialLin, S., Karoly, E. D., & Taatjes, D. J. (2013) · Aging Cell · doi:10.1111/acel.12108 · Cited by 16
Xia, L., Xing, Y., Ye, X., Wu, Y., Yang, Y., Yin, Z., Wang, A., Chen, J., & Zhang, M. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01480-0 · Cited by 14
“Additionally, upon DNA damage, the tumor suppressor TP53 promotes autophagy by stimulating AMPK or through transcription-dependent pathways that involve mTOR inhibitors and TP53-regulated autophagy genes like DRAM1 [5, 12 – 15].”
Li, W., Klovstad, M. S., & Schüpbach, T. (2014) · Development · doi:10.1242/dev.109306 · Cited by 15
“Alternatively, as some of the key regulators that mediate the inhibitory effect of DNA damage on translation in mammalian cells (such as p53) (Budanov and Karin, 2008; Cam et al., 2014) are not required by the Drosophila meiotic DNA damage checkpoint to repress Grk translation (Abdu et al.”
BackgroundMarín-Uribe, C. R., & Navarro-Gaete, R. (2021) · Materiales de Construcción · doi:10.3989/mc.2021.11520 · Cited by 17
Howe, O. L., White, L., Cullen, D., O’Brien, G., Shields, L., Bryant, J., Noone, E., Bradshaw, S., Finn, M. A., Dunne, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910607 · Cited by 15
“Therefore, SESN1 and SESN2 are important IR-induced mediators of the DDR via P53 and mTOR signaling pathway [17].”
BackgroundWang, M., Zhang, Z., Li, Z., Zhu, Y., & Xu, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1226057 · Cited by 16
Yang, Z., Ma, X., Zhang, D., Li, B., Gao, N., Li, X., Mei, C., & Zan, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133650 · Cited by 15
Regulatory Effects of Sestrin 3 (SESN3) in BCR-ABL Expressing Cells
Vakana, E., Arslan, A. D., Szilard, A., Altman, J. K., & Platanias, L. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078780 · Cited by 15
“While the sestrin family of proteins was first implicated in redox control [30,31,32], recent studies have been focusing on the role of sestrins in mTORC1 signaling.”
BackgroundInfluentialExercising insulin sensitivity: AMPK turns on autophagy!
Dagon, Y., Mantzoros, C. S., & Kim, Y. (2015) · Metabolism · doi:10.1016/j.metabol.2015.03.002 · Cited by 16
“Interestingly, Sestrins also suppressed the mTOR signaling cascade through AMPK dependent (24) or independent pathway (25).”
BackgroundSui, X., Fang, Y., Lou, H., Wang, K., ZHENG, Y., Lou, F., JIN, W., Xu, Y., Chen, W., Pan, H., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2853 · Cited by 15
“…p53 is able to inhibit the mTOR pathway through a number of known p53 transcriptional targets, including AMP-activated protein kinase, tuberous sclerosis complex 2, phosphatase and tensin homolog (PTEN), and sestrins, all of which are upstream negative regulators of the mTOR pathway (30,31).”
RetractedSmiles, W. J., & CAMERA, D. M. (2017) · Acta Physiologica · doi:10.1111/apha.13004 · Cited by 15
Cестрины – шлагбаумы на путях от стресса к старению и болезням
Dalina, A. A., Kovaleva, I. E., & Budanov, A. V. (2018) · Molecular Biology · doi:10.1134/s0026898418060046 · Cited by 15
Self-citationEl-Masry, O. S., BROWN, B. L., & Dobson, P. R. M. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.12.3763 · Cited by 15
“On the other hand, it is activated downstream of the p53 transcription targets, sestrin 1 and 2 (Levine et al., 2006; Budanov and Karin, 2008) and the β subunit of AMPK is encoded by a p53 responsive gene (Feng et al., 2007).”
Background
Metadata
- Authors
- Budanov, A. V., & Karin, M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 134
- Issue
- 3
- Pages
- 451-460
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC2758522
- OpenAlex
- W1972618720
- Cited by
- 1,326
- References
- 50
- Citations by year
- 2026: 31 · 2025: 56 · 2024: 60 · 2023: 56 · 2022: 86 · 2021: 94 · 2020: 110 · 2019: 85 · 2018: 81 · 2017: 85 · 2016: 87 · 2015: 78 · 2014: 85 · 2013: 71 · 2012: 89
- FWCI
- 23.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1847 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Funders
- National Institute of Environmental Health Sciences (P42ES010337, 5R01 ES0637, R37ES004151, R01ES006376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- p53, Sestrin2, mTOR signaling, TSC2, TSC1/TSC2 complex, AMPK, genotoxic stress, oxidative stress, p53 target genes, cell growth regulation, tumor suppression
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Sestrins, Animals, Cell Line, DNA Damage, Humans, Mice, Inbred C57BL, Multienzyme Complexes, Nuclear Proteins, Peroxidases, Proteins, Signal Transduction, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Cell Line, Tumor, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review